Polpharma Biologics
Konstantin Matentzoglu is an accomplished professional in the biotechnology and pharmaceuticals sector, currently serving as a Member of the Supervisory Board at Polpharma Biologics and BSP Pharmaceuticals S.p.A., and as a Partner at CDL Therapeutics GmbH and PREDICTION BIOSCIENCES. Previous roles include CEO and Member of the Supervisory Board at Celonic Group, and Partner at Trenzyme GmbH. Konstantin Matentzoglu holds a promotion in biochemistry from the University of Konstanz and has a Diplom in biology from Universität Köln. Further educational experiences include studies at NKI Amsterdam and LCBS.
This person is not in any teams
This person is not in any offices
Polpharma Biologics
1 followers
Polpharma Biologics is a division of Polpharma Group - one of the largest pharmaceutical companies in Central and Eastern Europe.